Navigation Links
Jean-Pierre Lehner Appointed Chief Medical Officer
Date:2/11/2009

PARIS, Feb. 11 /PRNewswire-FirstCall/ -- Sanofi-aventis announced today that Jean-Pierre Lehner, M.D., is appointed Senior Vice-President, Chief Medical Officer (CMO). He was previously Senior Vice President, Medical & Regulatory Affairs.

Jean-Pierre Lehner reports to Marc Cluzel, Senior Vice President, Research & Development, who declared: "The newly created role of Chief Medical Officer is a further demonstration internally and externally of the company's commitment to patient well being".

Patient safety is of the utmost importance to sanofi-aventis. Given the new tools available to enhance pharmacovigilance and monitor the safety of products in development as well as those on the market, this position combines all of the functions related to patient safety to enhance the clarity of purpose and accountability within the company. Pharmacovigilance and Regulatory Affairs will report to the CMO.

The CMO will also chair the internal Benefit/Risk Assessment Committee created in 2008 and which has direct accountability for its conclusions to the CEO.

Jean-Pierre Lehner holds a Medical degree from the School of Medicine University of Paris, France. After spending four years as Chef de Clinique, assistant of Paris Hospitals, Department of Cardiology (Pr Tricot), Hopital Bichat, Paris, France, Jean-Pierre Lehner joins Roussel Laboratories in 1981 as Medical Director (1981-1986), then he is named Medical Director of Roussel-Uclaf (1986-1992). He is successively Senior Director of Clinical Investigations of Sanofi Recherche (1992-1996), Scientific Senior Director of Sanofi Winthrop (1996-2002), Vice President Medical Affairs Europe of sanofi-aventis (2003-2005). As from 2005, Jean-Pierre Lehner was Senior Vice-President, Medical & Regulatory Affairs sanofi-aventis.

About sanofi-aventis

Sanofi-aventis, a leading global pharmaceutical company, discovers, develops and distributes therapeutic solutions to improve the lives of everyone. Sanofi-aventis is listed in Paris (EURONEXT: SAN) and in New York (NYSE: SNY).

    CONTACT:  Jean-Marc Podvin
              Vice President, Media Relations
              sanofi-aventis
              +331-53-77-4223


'/>"/>
SOURCE sanofi-aventis
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Alice Stollenwerk Petrulis, MD, FACP, Appointed to NQF Care Coordination Committee
2. Former Assistant Secretary for Aging, The Honorable Josefina G. Carbonell, Appointed Senior Vice President at Independent Living Systems
3. Perrigo Company Appointed Generic Distributor by Medimetriks Pharmaceuticals
4. Asthma & Allergy Foundation CEO Appointed to NIH Council
5. Ad de Waard Appointed Vice President of International Sales and Marketing at Accumetrics, Inc.
6. Latino Psychologist Appointed to Mental Health Post in Commonwealth
7. Dr. Jane L. Delgado Appointed By Senate Majority Leader to Board of National Urban Air Toxics Research Center
8. Universal Health Realty Income Trust Announces Marc D. Miller Appointed to Board of Trustees and Dividend Increase
9. Craig A. Norris Appointed to Providence Service Corporation Board of Directors
10. Jonathan Jacobson Appointed General Manager, Global Business Strategies & Operations, Menicon Co., Ltd.
11. Mobile Imaging Innovator, Mobile Diagnostic Centers LP, Appoints New CEO : Mobile Imaging Development's Limited Partnership, Mobile Diagnostic Centers LP. Has Appointed Patrick McNamara as CEO
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2016)... Newport Beach, CA (PRWEB) , ... December 04, ... ... youthful appearance without undergoing major cosmetic surgery can now take advantage of a ... is an advanced skin rejuvenation treatment that reduces the appearance of age spots, ...
(Date:12/4/2016)... ... December 04, 2016 , ... Responsible dental care hinges on regular ... to achieve optimal results. This important necessity inspired an inventor from Las Vegas, Nev., ... to ensure that people break or avoid bad techniques of brushing the teeth in ...
(Date:12/2/2016)... ... December 02, 2016 , ... Lori G. Cohen and ... office, will speak at the American Conference Institute’s 21st Drug & Medical Device ... a Lead Sponsor of the conference. , Cohen, who chairs the firm’s Pharmaceutical, Medical ...
(Date:12/2/2016)... Calif. (PRWEB) , ... December 02, 2016 , ... On ... at the Hard Rock Hotel San Diego honoring the 2016 MPN Heroes—eight individuals who ... neoplasms (MPNs) by going above and beyond the standard of care, demonstrating leadership within ...
(Date:12/2/2016)... ... December 02, 2016 , ... ... Area in Alabama are expected to attend the UNCF Dothan-Wiregrass Mayor’s Luncheon Dec. ... scholarship funds for area students and operating support to UNCF-member institutions, including Miles ...
Breaking Medicine News(10 mins):
(Date:12/2/2016)... , December 2, 2016 Orthopedic ... & Support) is Expected to Gain a Significant Market Share ... Orthopedic Ailments  ... , According to a ... on Medical Implants Sterile Packaging: Clamshell Product Type Segment Projected ...
(Date:12/2/2016)... N.J. , Dec. 2, 2016   CytoSorbents ... immunotherapy leader commercializing its European Union approved CytoSorb ... and cardiac surgery patients worldwide, announced that Dr. ... the 9th Annual LD Micro Main Event ... , 2016 at the Luxe Sunset Boulevard Hotel in ...
(Date:12/2/2016)... , December 2, 2016 On Thursday, ... 1.36%; the Dow Jones Industrial Average edged 0.36% higher, to ... down 0.35%. Losses were broad based as six out of ... initiated research reports on the following Services equities: Myriad Genetics ... QGEN ), INC Research Holdings Inc. (NASDAQ: ...
Breaking Medicine Technology: